Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
Karl H. Plate, Alexander Scholz, Daniel Dumont
Acta Neuropathologica (2012) Vol. 124, Iss. 6, pp. 763-775
Open Access | Times Cited: 236

Showing 1-25 of 236 citing articles:

Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
Olaf van Tellingen, Bahar Yetkin-Arik, Mark C. de Gooijer, et al.
Drug Resistance Updates (2015) Vol. 19, pp. 1-12
Closed Access | Times Cited: 864
The role of microenvironment in tumor angiogenesis
Xianjie Jiang, Jie Wang, Xiangying Deng, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 509
Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art
Reatul Karim, Claudio Palazzo, Brigitte Évrard, et al.
Journal of Controlled Release (2016) Vol. 227, pp. 23-37
Closed Access | Times Cited: 225
Angiopoietin‐2: a multifaceted cytokine that functions in both angiogenesis and inflammation
Alexander Scholz, Karl H. Plate, Yvonne Reiss
Annals of the New York Academy of Sciences (2015) Vol. 1347, Iss. 1, pp. 45-51
Closed Access | Times Cited: 209
Recent progress of drug nanoformulations targeting to brain
Abdur Rauf Khan, Xiaoye Yang, Manfei Fu, et al.
Journal of Controlled Release (2018) Vol. 291, pp. 37-64
Closed Access | Times Cited: 184
Glioma Stem Cells: Signaling, Microenvironment, and Therapy
Brandon Liebelt, Takashi Shingu, Xin Zhou, et al.
Stem Cells International (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 171
Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors
Evgenii Belykh, Kurt Shaffer, Chaoqun Lin, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 161
Targeting immunoliposomes to EGFR-positive glioblastoma
Benjamin Kasenda, David König, Michela Manni, et al.
ESMO Open (2022) Vol. 7, Iss. 1, pp. 100365-100365
Open Access | Times Cited: 71
Exosomes: Promising Delivery Tools for Overcoming Blood-Brain Barrier and Glioblastoma Therapy
Seyyed Hossein Khatami, Neda Karami, Mortaza Taheri‐Anganeh, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4659-4678
Open Access | Times Cited: 43
Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors
Susan Brandenburg, Annett Müller, Kati Turkowski, et al.
Acta Neuropathologica (2015) Vol. 131, Iss. 3, pp. 365-378
Closed Access | Times Cited: 176
Glioma therapy using tumor homing and penetrating peptide-functionalized PEG–PLA nanoparticles loaded with paclitaxel
Quanyin Hu, Xiaoling Gao, Guangzhi Gu, et al.
Biomaterials (2013) Vol. 34, Iss. 22, pp. 5640-5650
Closed Access | Times Cited: 163
A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment
Da Wang, Chao Wang, Liang Wang, et al.
Drug Delivery (2019) Vol. 26, Iss. 1, pp. 551-565
Open Access | Times Cited: 142
Cerebral microvascular pericytes and neurogliovascular signaling in health and disease
Turgay Dalkara, Luis Alarcón-Martínez
Brain Research (2015) Vol. 1623, pp. 3-17
Closed Access | Times Cited: 130
Tumor vasculature and glioma stem cells: Contributions to glioma progression
Niyati Jhaveri, Thomas C. Chen, Florence M. Hofman
Cancer Letters (2014) Vol. 380, Iss. 2, pp. 545-551
Closed Access | Times Cited: 129
The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas
Hongxiang Wang, Tao Xu, Ying Jiang, et al.
Neoplasia (2015) Vol. 17, Iss. 3, pp. 239-255
Open Access | Times Cited: 127
Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas
Alexandre Vallée, Rémy Guillevin, Jean-Noël Vallée
Reviews in the Neurosciences (2017) Vol. 29, Iss. 1, pp. 71-91
Closed Access | Times Cited: 119
miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas
Shouwei Li, Ailiang Zeng, Qi Hu, et al.
Neuro-Oncology (2016) Vol. 19, Iss. 1, pp. 55-65
Open Access | Times Cited: 118
Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma
Morgane Sanzey, Siti Aminah Abdul Rahim, Anaïs Oudin, et al.
PLoS ONE (2015) Vol. 10, Iss. 5, pp. e0123544-e0123544
Open Access | Times Cited: 113
Notch1 Stimulation Induces a Vascularization Switch With Pericyte-Like Cell Differentiation of Glioblastoma Stem Cells
Pierre‐Olivier Guichet, Sophie Guelfi, Marisa Teigell, et al.
Stem Cells (2014) Vol. 33, Iss. 1, pp. 21-34
Open Access | Times Cited: 112
Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway
Yingjun Zhu, Xihong Liu, Peiyuan Zhao, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 108
Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
Francesco Girolamo, Cristiana Coppola, Doménico Ribatti, et al.
Acta Neuropathologica Communications (2014) Vol. 2, Iss. 1
Open Access | Times Cited: 107
Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors
Shriya Reddy, Katyayani Tatiparti, Samaresh Sau, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 8, pp. 1944-1952
Open Access | Times Cited: 102
ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas
David Gomez‐Zepeda, Méryam Taghi, Jean‐Michel Scherrmann, et al.
Pharmaceutics (2019) Vol. 12, Iss. 1, pp. 20-20
Open Access | Times Cited: 100
Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma
Hanmei Li, Yuna Tong, Lan Bai, et al.
International Journal of Biological Macromolecules (2017) Vol. 107, pp. 204-211
Closed Access | Times Cited: 98
Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update
Mayra Colardo, Marco Segatto, Sabrina Di Bartolomeo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4899-4899
Open Access | Times Cited: 98
Page 1 - Next Page

Scroll to top